High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$172M
$172,499,918
Total Sells (Filtered)
$64.5M
$64,451,693
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -14.0%
|
2026-03-11 | $930,207 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -14.0%
2026-03-11
$1,070,511Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -14.0%
|
2026-03-11 | $1,070,511Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-11 | $144,955 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-11 | $870,000 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$41,326
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $41,326 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $41,326 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$38,721
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $38,721 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$123,267
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $123,267 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$214,207
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $214,207 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $38,721 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $123,267 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $214,207 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $33,095 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $171,518 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $98,648 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $31,012 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $33,896 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $99,251 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $905,987 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $178,924 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$273,276
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $273,276 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$93,368
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $93,368 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$132,504
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $132,504 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $126,025 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $48,175 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $368,761 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $6,472,596Whale | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2026-02-25 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $748 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $139,308 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $302,166 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $491,179 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $1,774,412Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-02-20 | $122,750 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-02-20 | $52,860 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -76.0%
2026-02-20
$165,410
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -76.0%
|
2026-02-20 | $165,410 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $13,704 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $26,672 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -96.1%
2026-01-20
$333,145
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -96.1%
|
2026-01-20 | $333,145 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-01-20 | $122,750 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-01-20 | $93,600 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-12-17 | $99,985 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-17 | $84,070 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -80.4%
2025-12-17
$342,064
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -80.4%
|
2025-12-17 | $342,064 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -61.0%
2025-12-17
$655,362
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -61.0%
|
2025-12-17 | $655,362 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -52.6%
2025-12-17
$1,182,984Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -52.6%
|
2025-12-17 | $1,182,984Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $93,600 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $332,040 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $616,843 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-12 | $51,893 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-12 | $9,832 | S | Form 4 |
|
KYMR
P
Kymera Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +30.1%
2025-12-11
$158,121,406MEGA
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +30.1%
|
2025-12-11 | $158,121,406MEGA | P | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-11 | $467,554 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-11 | $89,040 | S | Form 4 |
|
KYMR
P
Kymera Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +31.3%
2025-12-11
$14,378,512MEGA
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +31.3%
|
2025-12-11 | $14,378,512MEGA | P | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$8,002,338Whale
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $8,002,338Whale | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $529,979 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $302,647 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $180,370 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $837,235 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$1,522,702Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $1,522,702Large | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$2,788,526Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $2,788,526Large | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$1,590,881Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $1,590,881Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $950,526 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$4,375,521Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $4,375,521Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Mainolfi Nello
• CEO
10b5-1 SellΔOwn -13.2%
2025-12-08
$8,917,000Whale
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -13.2%
|
2025-12-08 | $8,917,000Whale | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-12-08 | $208,000 | M | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Equity Compensation
2025-12-08
$0
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$129,066
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $129,066 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$301,831
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $301,831 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$771,630
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $771,630 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$351,356
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $351,356 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.6%
2025-12-08
$1,615,811Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.6%
|
2025-12-08 | $1,615,811Large | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$1,202,139Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $1,202,139Large | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-12-08
$262,806
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-12-08 | $262,806 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-08 | $203,363 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Albers Jeffrey W.
• Director
10b5-1 SellΔOwn -55.0%
2025-12-08
$245,460
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -55.0%
|
2025-12-08 | $245,460 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-08 | $70,900 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $1,495,627Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $111,203 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-10-29 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $222,907 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-15
$407,099
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-15 | $407,099 | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-15
$37,989
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-15 | $37,989 | M | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-15
$46,197
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-15 | $46,197 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -17.3%
2025-10-15
$1,766,668Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -17.3%
|
2025-10-15 | $1,766,668Large | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-15
$551,161
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-15 | $551,161 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.3%
2025-10-15
$934,326
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.3%
|
2025-10-15 | $934,326 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-13
$186,840
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-13 | $186,840 | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-13
$1,400
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-13 | $1,400 | M | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-13
$1,048
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-13 | $1,048 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-13 | $295,949 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-10-13 | $51,700 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Jacobs Bruce N.
• CFO
10b5-1 SellΔOwn -25.8%
2025-09-17
$3,961,380Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -25.8%
|
2025-09-17 | $3,961,380Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Other
|
2025-09-17 | $164,778 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-09-16 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-16 | $1,470,000Large | S | Form 4 |